17Jan
TCI’s 1st-ever certificate of analysis following post-marketing surveillance
A significant milestone as a result of the partnership formed with CARPHA's Medicines Quality Control and Surveillance Department (MQCSD)as a part of their risk-based Post-Market Surveillance (PMS) Programme for medicines.
Source: Turks and Caicos Islands Government
Link to article
Link to social media